Abstract
BackgroundAssociations between demographic data and pulmonary function have not been adequately examined in patients that underwent Roux-en-Y Gastric Bypass (RYGB). This study was designed to examine changes in body fat distribution and metabolic parameters after RYGB and whether these changes correlated with improved lung function.MethodsA retrospective review of 32 ethnic Chinese with obesity with body mass index (BMI) 28–35 kg/m2 and type 2 diabetes (T2DM) was conducted, focusing on metabolic outcomes and pulmonary function 6 months after RYGB.ResultsForced expiratory volume during first second (FEV1), percentage of forced expiratory volume during first second (FEV1 [%pred]), forced vital capacity (FVC), and percentage of forced vital capacity (FVC [%pred]) all improved significantly after RYGB. These increases all were negatively correlated with decreases in body weight and visceral fat area (VFA). The improvements of FEV1, FEV1 [%pred] and FVC were also negatively correlated with baseline of body weight and VFA. Furthermore, increases in FEV1 and FVC were independently associated with baseline of VFA (β = −0.003, P = 0.000; β = −0.004, P = 0.002, respectively).ConclusionsThe baseline of VFA and weight loss induced by RYGB independently correlated with improved pulmonary function in Chinese patients.
Highlights
Associations between demographic data and pulmonary function have not been adequately examined in patients that underwent Roux-en-Y Gastric Bypass (RYGB)
Significant reductions 6 months after surgery were noted in weight, body mass index (BMI), and levels of total cholesterol (TC), triglycerides (TG) and low-density lipoprotein cholesterol (LDL-c)
We found that visceral fat area (VFA) decreased significantly 6 months after laparoscopic RYGB (LRYGB)
Summary
Associations between demographic data and pulmonary function have not been adequately examined in patients that underwent Roux-en-Y Gastric Bypass (RYGB). Methods: A retrospective review of 32 ethnic Chinese with obesity with body mass index (BMI) 28–35 kg/m2 and type 2 diabetes (T2DM) was conducted, focusing on metabolic outcomes and pulmonary function 6 months after RYGB. Obesity adversely affects pulmonary function, especially in those exhibiting the restrictive pattern of functional impairment [1,2,3]. Such impairment is found in patients with impaired glucose tolerance (IGT), diabetes, metabolic syndrome and cardiovascular disease [3,4,5]. In T2DM patients with BMI < 35 kg/m2 who underwent RYGB, BMI decreased from 34.6 ± 0.8 kg/m2 to 25.8 ± 2.5 kg/m2 and
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have